Recent Study: Inherited Metabolic Disorders - Pipeline Review, H2 2013
Global Markets Direct's, 'Inherited Metabolic Disorders - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Inherited Metabolic Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Inherited Metabolic Disorders. Inherited Metabolic Disorders - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release